Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis

Lancet. 2018 Mar 10;391(10124):933. doi: 10.1016/S0140-6736(18)30533-6.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Antibodies, Monoclonal
  • Humans
  • Immune Checkpoint Inhibitors* / adverse effects
  • Myocarditis* / chemically induced

Substances

  • Immune Checkpoint Inhibitors
  • Antibodies, Monoclonal